tetano
Editor, Senior Moderator
AIDS. 2011 Apr 18. [Epub ahead of print]
Sero-incidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women in the US prior to vaccine availability.
Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, Minkoff H.
Source
aJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA bFood and Drug Administration, Bethesda, Maryland, USA cNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA dWeill Medical College of Cornell University, New York, New York, USA eGeorgetown University, Washington DC, USA fUniversity of California, San Francisco, California, USA gCORE Center / Stroger Hospital, Rush University, Chicago, Illinois, USA hUniversity of California, Los Angeles, California, USA iMaimonides Medical Center, Brooklyn, New York, USA.
Abstract
The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected April 1 - September 30, 2009 and the prior two years from Women's Interagency HIV Study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 count ≥350 cells/mm compared with HIV-uninfected women. Due to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.
PMID:
21505313
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21505313
Sero-incidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women in the US prior to vaccine availability.
Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, Minkoff H.
Source
aJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA bFood and Drug Administration, Bethesda, Maryland, USA cNational Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA dWeill Medical College of Cornell University, New York, New York, USA eGeorgetown University, Washington DC, USA fUniversity of California, San Francisco, California, USA gCORE Center / Stroger Hospital, Rush University, Chicago, Illinois, USA hUniversity of California, Los Angeles, California, USA iMaimonides Medical Center, Brooklyn, New York, USA.
Abstract
The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected April 1 - September 30, 2009 and the prior two years from Women's Interagency HIV Study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 count ≥350 cells/mm compared with HIV-uninfected women. Due to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.
PMID:
21505313
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/21505313